Stratagen Quantitative Prostate MRI Platform Pilot Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stratagen Quantitative Prostate MRI Platform Pilot Study — Stella

Home/Prostate Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Prostate Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Urology Clinic at Sawgrass, Rochester, New York

Virginia Urology, Richmond, Virginia

Key details

Sponsor

Stratagen Bio, Inc.

Enrollment target

~75 participants

Started

September 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

40 Years – 90 Years

Sex

Male only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.